Status:
UNKNOWN
Ischemic Heart Disease in Male With Prostate Adenocarcinoma
Lead Sponsor:
Dnipropetrovsk State Medical Academy
Conditions:
Ischemic Heart Disease
Prostate Adenocarcinoma
Phase:
NA
Brief Summary
The purpose of the study: to increase the efficiency of diagnosis, treatment and prediction of the course of coronary heart disease in patients with adenocarcinoma of the prostate gland, depending on ...
Detailed Description
Research methods: 1. general-clinical examination 2. Laboratory methods: * estimation of the generally accepted laboratory parameters * determination of blood lipid profile * Determination ...
Eligibility Criteria
Inclusion
- men aged 45-75 years
- presence of verified diagnosis of adenocarcinoma of the prostate gland,
- stable antitumor therapy for 6 months, verified diagnosis of CAD,
- stable cardiological therapy for the past 3 months,
- voluntary informed consent to participate in the study.
Exclusion
- age older than 75 years,
- female sex,
- metastatic lesion,
- chronic heart failure of the III-IV functional class (FC),
- arrhythmias that cause hemodynamic impairment and require antiarrhythmic correction (including ventricular arrhythmias of high gradation, atrial flutter , paroxysmal tachycardia, sinus node weakness syndrome, 2-3-degree AV block),
- AMI, acute cerebrovascular accident,
- diabetes mellitus (insulin-dependent diabetes mellitus) with a level of NvA1s\> 7%, hyperthyroidism and hypothyroidism level of TSH\> 10 mD / L, chronic renal failure (GFR \<30 ml / min / 1.73 m2),
- acute cardiac and renal insufficiency,
- obesity 4 degrees,
- cachexia.
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03474835
Start Date
January 15 2018
End Date
January 15 2019
Last Update
March 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SE Dnipropetrovsk medical academy
Dnipro, Ukraine